title: Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico.
abstract: OBJECTIVE
  This study aimed to determine the prevalence of and risk factors associated with elevated alanine aminotransferase (ALT) levels among a sample of normal weight, overweight and obese youth from two urban populations in Central Mexico.
  
  
  METHODS
  Baseline data from 1262 youth aged 8-19 years who participated in the Mexican Health Worker Cohort Study from March 2004 to April 2006 were reviewed, including 680 girls and 582 boys, with a total of 83 participants with elevated ALT level (>40 U/L). Information was obtained from self-administered questionnaires, anthropometric results and clinical measurements. Associations of interest were examined using multivariate logistic regression models.
  
  
  RESULTS
  A total of 3.8% of girls and 9.8% of boys had elevated ALT levels. Elevated ALT was observed in 28.9% of the obese and 14.2% of the overweight participants. Metabolic syndrome (MS) occurred in 6.1% of the study population and those with MS had a high percentage of elevated ALT (14.5% of girls and 40.0% of boys, respectively). Abdominal obesity and insulin resistance were also associated with a greater risk of elevated ALT.
  
  
  CONCLUSIONS
  Obesity and certain metabolic risk factors are important predictors for elevated ALT. Screening for ALT levels in obese youth could help to identify those at risk and reduce the possibility of future liver diseases.
authors.affiliation: UCLA Department of Epidemiology, Fielding School of Public Health, Jonsson Comprehensive Cancer Center, Los Angeles, California, USA.
authors.forename: Maura
authors.initials: M
authors.lastname: Purcell
authors.forename: Yvonne N
authors.initials: YN
authors.lastname: Flores
authors.forename: Zuo-Feng
authors.initials: ZF
authors.lastname: Zhang
authors.forename: Edgar
authors.initials: E
authors.lastname: Denova-Gutiérrez
authors.forename: Jorge
authors.initials: J
authors.lastname: Salmeron
mesh_terms: D000293:Adolescent; D000410:Alanine Transaminase / Q000097:blood*; D000886:Anthropometry / Q000379:methods; D015415:Biomarkers / Q000097:blood; D001835:Body Weight / Q000502:physiology; D002648:Child; D004796:Clinical Enzyme Tests / Q000379:methods; D003430:Cross-Sectional Studies; D005234:Fatty Liver / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000201:enzymology / Q000453:epidemiology; D008800:Mexico / Q000453:epidemiology; D065626:Non-alcoholic Fatty Liver Disease; D009765:Obesity / Q000150:complications / Q000201:enzymology / Q000453:epidemiology; D050177:Overweight / Q000150:complications* / Q000201:enzymology / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D012737:Sex Factors; D055815:Young Adult
chemical_list: D015415:Biomarkers; D000410:Alanine Transaminase
keywords: Mexico; adolescent; liver disease; metabolic syndrome; obesity